We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+10.32%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$136M
AUM Growth
–
Cap. Flow
+$524M
Cap. Flow %
386.8%
Top 10 Hldgs %
40.45%
Holding
204
New
204
Increased
–
Reduced
–
Closed
–

Top Buys

1
GILD icon
Gilead Sciences
GILD
+$13M
2
CMG icon
Chipotle Mexican Grill
CMG
+$8.2M
3
CELG
Celgene Corp
CELG
+$6.34M
4
CMRX
Chimerix, Inc.
CMRX
+$5.55M
5
DYAX
DYAX CORPORATION
DYAX
+$5.42M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 43.09%
2 Consumer Discretionary 6.1%
3 Materials 3.81%
4 Consumer Staples 3.68%
5 Technology 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
126
PUT
DELISTED
bluebird bio
BLUE
$116K 0.09%
+3,111
New +$3.11M
LUMO
127
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$114K 0.08%
+16,789
New +$5.46M
BRCM
128
PUT
DELISTED
BROADCOM CORP CL-A
BRCM
$114K 0.08%
+19,900
New +$1.07M
SIOX
129
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$108K 0.08%
+3,038
New +$395K
BRCM
130
CALL
DELISTED
BROADCOM CORP CL-A
BRCM
$108K 0.08%
+33,400
New +$1.8M
EA icon
131
PUT
Electronic Arts
EA
$52.1B
$101K 0.07%
+54,700
New +$3.84M
TIF
132
CALL
DELISTED
Tiffany & Co.
TIF
$99K 0.07%
+23,600
New +$1.84M
IBM icon
133
PUT
IBM
IBM
$206B
$98K 0.07%
+31,380
New +$4.22M
UTHR icon
134
CALL
United Therapeutics
UTHR
$22.5B
$90K 0.07%
+15,200
New +$2.21M
ICPT
135
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$89K 0.07%
+33,200
New +$5.62M
BLUE
136
CALL
DELISTED
bluebird bio
BLUE
$87K 0.06%
+5,620
New +$5.61M
LNKD
137
CALL
DELISTED
LinkedIn Corporation
LNKD
$82K 0.06%
+11,800
New +$2.68M
LNKD
138
PUT
DELISTED
LinkedIn Corporation
LNKD
$82K 0.06%
+9,100
New +$2.07M
PTCT icon
139
CALL
PTC Therapeutics
PTCT
$6.51B
$80K 0.06%
+57,100
New +$1.68M
TIF
140
PUT
DELISTED
Tiffany & Co.
TIF
$80K 0.06%
+35,500
New +$2.77M
MNST icon
141
PUT
Monster Beverage
MNST
$97.7B
$77K 0.06%
+126,000
New +$3.04M
CLVS
142
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$77K 0.06%
+39,700
New +$2.56M
LRMR icon
143
CALL
Larimar Therapeutics
LRMR
$381M
$76K 0.06%
+7,500
New +$1.2M
VZ icon
144
PUT
Verizon
VZ
$183B
$70K 0.05%
+37,500
New +$1.7M
AMGN icon
145
PUT
Amgen
AMGN
$201B
$68K 0.05%
+16,200
New +$2.55M
LLY icon
146
PUT
Eli Lilly
LLY
$1.04T
$67K 0.05%
+15,500
New +$1.29M
PEP icon
147
CALL
PepsiCo
PEP
$190B
$66K 0.05%
+95,100
New +$9.49M
AGN
148
CALL
DELISTED
Allergan plc
AGN
$57K 0.04%
+12,500
New +$3.72M
YUM icon
149
PUT
Yum! Brands
YUM
$41.9B
$56K 0.04%
+41,730
New +$2.18M
GE icon
150
PUT
GE Aerospace
GE
$361B
$54K 0.04%
+21,075
New +$2.99M
4 5
6
7 8

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q4 2015 Portfolio in Review

Q4 2015 is the first quarter with a 13F filing on record for FT Options, which disclosed 204 positions worth $136M. Its ten largest holdings account for 40% of the portfolio.

Its largest position is Gilead Sciences: 125,233 shares worth $12.7M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, followed by Consumer Discretionary and Materials.

  • FT Options's largest Q4 2015 buy was Gilead Sciences: 125,233 shares worth $12.7M.
  • FT Options's ten largest holdings make up 40% of its $136M portfolio in Q4 2015.
  • FT Options disclosed 204 positions in Q4 2015, its first 13F filing on record.

Based on FT Options's 13F filing for Q4 2015, filed 5 Feb 2016.